PFBT
MBOT icon

Parkside Financial Bank & Trust’s Microbot Medical MBOT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-42
Closed – – 2031
2022
Q3 		$0 Hold
42
– – ﹤0.01% 1877
2022
Q2 		$0 Buy
+42
New +$234 ﹤0.01% 1891

Other funds holding MBOT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Parkside Financial Bank & Trust's MBOT Position: Q4 2022 in Review

Parkside Financial Bank & Trust sold out of Microbot Medical (MBOT) in Q4 2022, closing a stake of 42 shares.

Parkside Financial Bank & Trust first reported a position in MBOT in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 24 funds tracked by Wall St. Rank hold MBOT as of Q4 2022.

  • Parkside Financial Bank & Trust reported no remaining Microbot Medical position as of Q4 2022 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 42 Microbot Medical shares in Q4 2022.
  • Parkside Financial Bank & Trust first reported a position in Microbot Medical in Q2 2022 and held it in 2 quarters.
  • Parkside Financial Bank & Trust's Microbot Medical position peaked at $0 in Q3 2022.
  • 24 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2022.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2022, filed 14 Feb 2023.